Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as well as regulatory decisions to inform healthcare’s most critical decisions, advance access to medications, and ultimately improve patient care.
Nicolle is an epidemiologist with 20 years of industry experience. She serves as a senior scientific voice ensuring appropriate and principled use of real-world data/evidence. She received her PhD from Columbia University in New York City. Prior to Aetion, Nicolle was the Group Head for Vaccines and Oncology with the Epidemiology Group at Pfizer. Nicolle is a Fellow of the International Society for Pharmacoepidemiology and an Adjunct Assistant Professor of Epidemiology at Columbia University and Tulane, teaching courses in pharmacoepidemiology, causal inference and confounding control methods.